Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Amphastar Boosted By Baqsimi And Shortages

The Recently Acquired Asset Drove Company Revenue Growth In Q1

May 28 2024

• By Adam Zamecnik

Q1 Illustrative image — • Source: Shutterstock

Related Content

Supplier Shortages To Benefit Amphastar For Many Quarters To Come

Nov 23 2023

Amphastar Taps Private Financing After Major Eli Lilly Acquisition

Sep 13 2023

Pfizer Rallies To Fix Tornado Damage At Key Injectables Plant

Jul 24 2023

Lilly Offloads Baqsimi To Amphastar While Investing In Mounjaro Head-To-Head Trial

Apr 24 2023

US Aspart Filing Kicks Off Amphastar’s Insulin Ambitions

Mar 18 2024

Amphastar Grows With Primatene Mist, Epinephrine And Glucagon

Mar 21 2022

Primatene Mist Drives Amphastar Sales Growth

Mar 23 2022

Related Companies

Amphastar Pharmaceuticals, Inc.

Additional Topics

United States Biosimilars Generic Drugs Sales & Earnings

More from Biosimilars

More from Products

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window